XOMA TECHNOLOGY LTD.

M-CSF specific monoclonal antibody and uses thereof

#2 | 2016-10-06 ✅ Patent 10,167,334 granted on 2019-01-01

US20160289315A1

Treatment of cancer using anti-TGF-BETA and PD-1 antibodies

#3 | 2016-01-21 ✅ Patent 9,522,186 granted on 2016-12-20

US20160015809A1

M-CSF specific monoclonal antibody and uses therof

#4 | 2015-11-12 ✅ Patent 9,714,285 granted on 2017-07-25

US20150322146A1

TGF-beta-specific antibodies and methods of use thereof for treatment

#5 | 2015-10-29

US20150308988A1

Antibody Coformulations

#6 | 2015-07-02 ✅ Patent 9,541,004 granted on 2017-01-10

US20150183872A1

Antagonist antibodies against EphB3

#7 | 2015-04-23

US20150110783A1

ANTAGONIST ANTI-CD40 ANTIBODY PHARMACEUTICAL COMPOSITIONS

#8 | 2015-03-26

US20150086991A1

USES OF ANTI-CD40 ANTIBODIES

#9 | 2014-09-11 ✅ Patent 9,163,082 granted on 2015-10-20

US20140255391A1

Methods for the treatment of IL-1β related diseases

#10 | 2014-08-28 ✅ Patent 9,139,646 granted on 2015-09-22

US20140242090A1

Methods for the treatment of uveitis with IL-1β binding antibodies

#11 | 2014-08-28 ✅ Patent 9,079,956 granted on 2015-07-14

US20140242071A1

M-CSF specific monoclonal antibody and uses thereof

#12 | 2014-06-05 ✅ Patent 9,732,143 granted on 2017-08-15

US20140154743A1

Methods and materials for enhancing functional protein expression in bacteria

#13 | 2014-05-29 ✅ Patent 9,006,398 granted on 2015-04-14

US20140148584A1

EPHB3-specific antibody and uses thereof

#14 | 2014-01-30

US20140030738A1

SOLUBLE HUMAN M-CSF RECEPTOR AND USES THEREOF

#15 | 2014-01-23 ✅ Patent 9,145,458 granted on 2015-09-29

US20140023644A1

Antibodies specific for TGF-β and methods of treatment thereof

#16 | 2014-01-16

US20140017249A1

METHODS FOR IMPROVEMENT OF BETA CELL FUNCTION

#17 | 2014-01-02 ✅ Patent 9,206,252 granted on 2015-12-08

US20140004125A1

Pharmaceutical compositions comprising IL-1B binding antibodies and fragments thereof

#18 | 2013-09-05

US20130230528A1

METHODS FOR DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISORDERS MEDIATED BY CD40 SIGNALING

#19 | 2013-05-02 ✅ Patent 8,961,969 granted on 2015-02-24

US20130108638A1

Performing operations; transporting

Antagonist antibodies against EphB3

#20 | 2013-03-21 ✅ Patent 8,584,349 granted on 2013-11-19

US20130067721A1

Flexible manufacturing system

#21 | 2012-12-13 ✅ Patent 8,569,462 granted on 2013-10-29

US20120315282A1

Antibodies specific for TGF-beta and methods for treating thereof

#22 | 2012-07-12 ✅ Patent 8,497,096 granted on 2013-07-30

US20120178126A1

Methods and materials for increasing expression of recombinant polypeptides

#23 | 2012-07-05 ✅ Patent 8,318,162 granted on 2012-11-27

US20120171226A1

Antibodies to high molecular weight melanoma associated antigen

#24 | 2012-05-17 ✅ Patent 8,821,879 granted on 2014-09-02

US20120121581A1

Anti-botulism antibody coformulations

#25 | 2012-01-19 ✅ Patent 8,377,442 granted on 2013-02-19

US20120014967A1

Method of treating inflammatory eye disease with IL-1β binding antibodies

#26 | 2012-01-19 ✅ Patent 8,551,487 granted on 2013-10-08

US20120014966A1

Methods for the treatment of IL-1β related conditions

#27 | 2012-01-12 ✅ Patent 8,546,308 granted on 2013-10-01

US20120010101A1

Triple tag sequences and methods of use thereof

#28 | 2012-01-05 ✅ Patent 8,377,429 granted on 2013-02-19

US20120005127A1

Methods for improvement of beta cell function with anti-IL-1β antibodies or fragments thereof

#29 | 2012-01-05 ✅ Patent 8,545,846 granted on 2013-10-01

US20120003226A1

Methods for treating IL-1β related diseases by administering an anti-IL-1β antibody

#30 | 2011-12-29

US20110319598A1

METHODS AND MATERIALS FOR DETERMINING ISOELECTRIC POINT

#31 | 2011-12-15

US20110307439A1

METHODS AND APPARATUS FOR DISPLAYING PREDICTIONS ASSOCIATED WITH AN ALPHABETIC STRING

#32 | 2011-11-10 ✅ Patent 9,885,711 granted on 2018-02-06

US20110274692A1

Screening methods

#33 | 2011-09-22 ✅ Patent 8,273,355 granted on 2012-09-25

US20110229462A1

Hepatocyte growth factor (HGF) binding proteins

#34 | 2011-09-15 ✅ Patent 8,476,040 granted on 2013-07-02

US20110224102A1

Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries

#35 | 2011-08-04

US20110189172A1

METHODS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

#36 | 2011-06-23 ✅ Patent 9,005,614 granted on 2015-04-14

US20110150760A1

PRLR-specific antibody and uses thereof

#37 | 2011-05-19

US20110118447A1

METHODS AND MATERIALS FOR TARGETED AFFINITY ENHANCEMENT

#38 | 2011-05-19 ✅ Patent 9,102,711 granted on 2015-08-11

US20110118131A1

Methods and materials for targeted mutagenesis

#39 | 2011-03-31 ✅ Patent 8,926,976 granted on 2015-01-06

US20110076284A1

Modulators

#40 | 2011-02-17

US20110039722A1

LIBRARIES, ARRAYS AND THEIR USES FOR TARGETED AFFINITY ENHANCEMENT

#41 | 2011-02-17 ✅ Patent 8,586,036 granted on 2013-11-19

US20110038859A1

Methods for the treatment of IL-1β related diseases

#42 | 2010-12-16

US20100316651A1

CARDIOVASCULAR RELATED USES OF IL-1BETA ANTIBODIES AND BINDING FRAGMENTS THEREOF

#43 | 2010-12-02 ✅ Patent 8,101,166 granted on 2012-01-24

US20100303807A1

Methods for the treatment of IL-1β related diseases

#44 | 2010-07-22 ✅ Patent 8,546,307 granted on 2013-10-01

US20100184612A1

Triple tag sequence and methods of use thereof

#45 | 2010-07-08 ✅ Patent 7,943,344 granted on 2011-05-17

US20100173362A1

Hepatocyte growth factor (HGF) binding proteins

#46 | 2010-04-22 ✅ Patent 8,377,439 granted on 2013-02-19

US20100098711A1

Antagonist antibodies against EPHB3

#47 | 2010-04-15 ✅ Patent 8,652,469 granted on 2014-02-18

US20100092464A1

M-CSF-specific monoclonal antibody and uses thereof

#48 | 2010-03-11 ✅ Patent 7,943,121 granted on 2011-05-17

US20100061998A1

IL-1β binding antibodies and fragments thereof

#49 | 2010-03-04 ✅ Patent 7,988,968 granted on 2011-08-02

US20100055110A1

Method of treating an IL-1 related coronary condition

#50 | 2010-01-14 ✅ Patent 7,972,811 granted on 2011-07-05

US20100009857A1

Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries

#51 | 2009-12-10 ✅ Patent 8,945,564 granted on 2015-02-03

US20090304706A1

Antagonist anti-CD40 antibody pharmaceutical compositions

#52 | 2009-10-01 ✅ Patent 7,749,731 granted on 2010-07-06

US20090246831A1

Methods for recombinant peptide production

#53 | 2009-10-01 ✅ Patent 7,744,866 granted on 2010-06-29

US20090246210A1

IL-1β binding antibodies and binding fragments thereof

#54 | 2009-09-10 ✅ Patent 7,744,865 granted on 2010-06-29

US20090226461A1

IL1-β Binding antibodies and fragments thereof

#55 | 2009-08-27 ✅ Patent 7,829,093 granted on 2010-11-09

US20090214568A1

Method of treating an IL-1 related autoimmune disease or condition

#56 | 2009-08-27 ✅ Patent 7,829,094 granted on 2010-11-09

US20090214545A1

Method of treating an IL-1 related cancer

#57 | 2009-08-13

US20090202531A1

USES OF ANTI-CD40 ANTIBODIES

#58 | 2009-07-16 ✅ Patent 8,637,029 granted on 2014-01-28

US20090181019A1

Methods for the treatment of gout

#59 | 2009-06-04 ✅ Patent 8,586,716 granted on 2013-11-19

US20090142261A1

EPHB3-specific antibody and uses thereof

#60 | 2009-05-07 ✅ Patent 8,926,979 granted on 2015-01-06

US20090117111A1

Treatment of cancer or pre-malignant conditions using anti-CD40 antibodies

#61 | 2009-03-05 ✅ Patent 7,695,717 granted on 2010-04-13

US20090060923A1

Method of treating an IL-1 related inflammatory disease or condition

#62 | 2009-03-05 ✅ Patent 7,582,742 granted on 2009-09-01

US20090060918A1

Method of treating or preventing an IL-1 related disease or condition

#63 | 2009-02-12 ✅ Patent 8,337,851 granted on 2012-12-25

US20090041773A1

Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancer

#64 | 2008-11-27 ✅ Patent 7,695,718 granted on 2010-04-13

US20080292640A1

Methods for the treatment of IL-1β related diseases

#65 | 2008-11-27 ✅ Patent 7,867,493 granted on 2011-01-11

US20080292620A1

PRLR-specific antibody and uses thereof

#66 | 2008-11-06 ✅ Patent 8,333,970 granted on 2012-12-18

US20080274118A1

Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune disease

#67 | 2008-10-02

US20080241126A1

Nucleic acids encoding Human Engineered heavy and light chain variable region sequences to Ep-CAM

#68 | 2008-09-04 ✅ Patent 7,977,068 granted on 2011-07-12

US20080214411A1

Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries

#69 | 2008-07-08 ✅ Patent 7,396,661 granted on 2008-07-08

US10367169

Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries

#70 | 2008-06-19

US20080145895A1

Methods and Materials for Increasing Expression of Recombinant Polypeptides

#71 | 2008-06-19 ✅ Patent 7,794,976 granted on 2010-09-14

US20080145894A1

Methods and materials for expression of a recombinant protein

#72 | 2008-05-29

US20080124762A1

Methods and Materials for Expression of a Recombinant Protein

#73 | 2008-05-22

US20080119410A1

Modulation of Pericyte Proliferation

#74 | 2008-05-08 ✅ Patent 7,649,083 granted on 2010-01-19

US20080108565A1

Hepatocyte growth factor (HGF) binding antibody

#75 | 2007-12-06 ✅ Patent 7,993,915 granted on 2011-08-09

US20070281334A1

Methods and materials for increasing expression of recombinant polypeptides

#76 | 2007-07-24 ✅ Patent 7,247,454 granted on 2007-07-24

US10324182

Methods for recombinant peptide production

#77 | 2007-03-20 ✅ Patent 7,192,737 granted on 2007-03-20

US10404724

Methods and materials for increasing expression of recombinant polypeptides

#78 | 2006-08-03

US20060171937A1

Method of treating chronic cardiac disease

#79 | 2005-07-14 ✅ Patent 7,291,451 granted on 2007-11-06

US20050153889A1